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ostia under visual control to prevent an
aggravation of the type A dissection or
induction of infective emboli with the
tip of the heart catheter. In all our pa-
tients, we had to open the aortic root
to deliver the cardioplegic solution and
surgical repair; thus, performing the
ICA was a subsequent procedure em-
bedded into the surgical flow, and
preparation of the C arm was done
simultaneously while cannulating. The
prolongation of the ACC (and the total
operation time) took a mean of 12 min-
utes, and the overall myocardial ische-
mic time did not exceed 105 minutes
for any patient. We believe that the de-
scribed prolongation of ACC for these
patients, who were not primarily admit-
ted for coronary artery bypass grafting,
is acceptable. Furthermore, a beating
heart coronary bypass to the circumflex
artery after aortic valve replacement re-
quiring a luxation of the heart may risk
a perforation of the prosthetic stents
after aortic valve replacement.
The second issue highlighted by
D’Onofrio and colleagues is a more
physiologic depiction of the coronaries,
including milking and contrast dye
washout while performing ICA on the
beating heart. In patients undergoing
coronary bypass, we also perform ICA
on the beating heart and especially in
patients during off-pump coronary by-
pass procedures for quality control. In
these patients, we also deliver the con-
trast medium to the opened chest to
depict the distal anastomoses and the
following native coronary portions.
As a positive effect in our patients
presenting with acute aortic dissection
type A or endocarditis, conducting
ICA directly via the coronary ostia
during ACC1 may offer increased im-
aging quality because of the exclusive
delivery of the contrast medium with-
out sanguineous dilution.
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TRANSBRONCHIAL NEEDLE
ASPIRATION DIAGNOSTIC
YIELD IN SARCOIDOSIS
To the Editor:
We have read with attention the ex-
cellentwork ofTrisolini and associates1
regarding predictor variables for trans-
bronchial needle aspiration (TBNA)
yield in sarcoidosis that was published
in the April 2008 issue of the Journal.
Regarding the results from the analysis
of our experience in mediastinal and
hilar lymph node TBNA in sarcoidosis,
we have a few comments. In a 10-year
period, we performed TBNA in 82 dif-
ferent lymph nodes in 57 patients with
stage I or II sarcoidosis using a 19-
gauge histology needle (MW-319;
Bard-Wang, Billerica, Mass) in most
of the cases (93%). The number of di-
agnostic samples obtained was lower
than that reported by Trisolini and col-
leagues,1 because we obtained ade-
quate material representative of lymph
node tissue in 49 (59.8%) of 82 lymph
nodes sampled, although the nonnecro-
tizing epithelioid cell granulomas sar-
coidosis type was observed in 36
(63.1%) of 57 patients (Table 1). How-
ever, we did not identify any predictor
factor from that study. Although there
are several possible explanations for
these differences, we believe that two
main factors have the greater influence.
Trisolini and coworkers1 included allCardiovascular Surgery c June 2009cytologic samples systematically in
their analysis, which notably increased
the positive results.We did not perform
cytology samples systematically when
we performed TBNA with a histology
needle. In addition, as we reported pre-
viously,2 we usually performed TBNA
of the most accessible and enlarged
lymph node; we changed the lymph
node station only if diagnosis was not
achieved after three or four punctures.
It seems, as Trisolini’s group1 con-
cluded, that combining TBNA cytol-
ogy and histology and the systematic
puncture of several lymph node stations
can increase the positive diagnosis in
this disease. However, although using
cytology for sarcoidosis diagnosis is
widely reported,3,4 it is not generally ac-
cepted5; furthermore, a histologic diag-
nosis is preferable in cases of atypical
clinical presentation and in areas with
a high prevalence of tuberculosis infec-
tion,4 such as ours.6 In our study, none
of the 4 cases performed using cytology
needles were valid diagnotic samples.
What also was surprising about the
study by Trisolini and associates1 was
the low number of adequate TBNAhis-
tologic samples obtained (22.5% of
lymph nodes sampled and 30% of pa-
tients), a lower percentage than they
achieved in a previous study (both
>60%).7 Although the authors suggest
that a growing reliance on cytology
needles may explain the difference,
such a notable reduction in TBNA his-
tologic diagnostic yield in the 2-year
period between the end of one study
and the beginning of the other seems
unlikely, especially given their high
level of expertise. We suggest the
possibility that the reliably good results
with the cytologic samples have led
to their being less aggressive and
insistent in achieving adequate histo-
logicTBNAsamples, using a technique
that is,moreover, clearlymore difficult.
We agree with the authors that com-
bining TBNA with transbronchial lung
biopsy and bronchoalveolar lavage can
avoid the necessity formediastinoscopy
in almost all patients with sarcoidosis
formed with the standard ‘‘blind’’
method, demonstrated that the diagnosis
of sarcoidosis is feasible with TBNA
and that acceptable, yet variable, diag-
nostic yields are obtainable (46%–
90%).1-7 These studies, however, left
questions on the generalizability of the
findings inasmuch as they were mostly
retrospective,2,5-7 included small se-
ries,2,4,6-8 did not usually accept cyto-
logic TBNA samples as diagnostic,1-5,8
used only rigid needles,1 or lacked com-
puted tomographic guidance to map
lymph node areas to be sampled.4
More recently, a few studies designed
to overcome many of these design limi-
tations showed that a diagnostic yield of
more than75%is reproducible, at least in
expert settings.9-11 Nonetheless, remark-
able differences in study populations,
needle size used (19-gauge histology
versus 22-gauge cytology needle), path-
ologic examination (cytologic with or
without histologic material), availability
Letters to the EditorTABLE 1. Predictors of obtaining diagnostic samples after TBNA in sarcoidosis
Factors Diagnostic samples P value
Sex
Male 22/31 (71.0%) .2
Female 15/26 (57.7%)
Age*
<40 y 17/27 (62.9%) .9
40 y 19/30 (63.3%)
Pulmonary lesion (TCT)y
No 27/41 (65.9%) .4
Yes 9/16 (56.3%)
No. of lymph nodes punctured
One 21/32 (65.6%) .8
Two 16/25 (64.0%)
Lymph node station
Right paratracheal 15/27 (55.6%) .8
Subcarinal 27/33 (66.7%)
Otherz 7/12 (58.3%)
Diameter of the diseased lymph node*
<20 mm 20/34 (58.8%) .8
20 mm 29/48 (60.4%)
Indirect signsx
Yes 13/16 (81.2%) .08
No 36/66 (54.5%)
*Cutoff point based in the sample median. yTTC, Thoracic computed tomography. zNine hilar and 3 left paratracheal.
xExtrinsic compression, edema, or broadening of the carina in puncture sites.Reply to the Editor:
Transbronchial needle aspiration
(TBNA) has been increasingly used
over the past several years for the patho-
logic confirmation of sarcoidosis in pa-
tients with hilar or mediastinal node
enlargement. Early studies, all per-
of a real-time imaging guide (standard,
‘‘blind’’ TBNA versus ultrasound-
guided TBNA), and on-site facilities
(presence vs absence of rapid on-site cy-
topathologic examination) make it im-
portant to comment on the findings of
these recent studies to place TBNA re-
sults in sarcoidosis into proper context.
One extremely important aspect of
the studies specifically designed to as-
sess the value of TBNA in sarcoidosis
is that they were all subject to selection
bias. The pre-test probability of sarcoid-
osis in the study populations was very
high, inasmuch as they invariably in-
cluded patients with highly suggestive
clinical and radiologic findings.3,4,7-11
As a consequence, the excellent diag-
nostic yields that the authors obtained
are likely to be reproducible in this spe-
cific scenario.The success rateofTBNA
for sarcoidosis in studies enrolling clini-
cally unselected patients with enlarged
mediastinal nodes at imaging studies is
somewhat lower and depends mostly
on the prevalence of the disease in the
population being studied. Satisfactory
(>60%) diagnostic rates were reported
in study populations with sarcoidosis
prevalence of at least 35%,12,13 whereas
Supplemental material is
available online.stage I or II.1-3,5,7 Although endobron-
chial ultrasound techniques can help
improve the TBNA diagnosis yield,4
they are not always available. In addi-
tion, as has been demonstrated, ‘‘classic
TBNA’’ is still important in the thoracic
sarcoidosis diagnosis.
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